What is the Lumipulse test for Alzheimer’s disease? In May, the U.S. Food and Drug Administration permitted marketing of the Lumipulse (G B-Amyloid Ratio [1-42/1-40]) test to Fujirebio Diagnostics, ...
The FDA has approved the first blood test to detect signs of Alzheimer’s disease, marking a major step toward easier diagnosis. The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio test identifies ...
WASHINGTON (Reuters) - U.S. regulators gave the nod to an imaging test from Eli Lilly and Co. that can for the first time help doctors detect brain plaque tied to Alzheimer's disease, the company said ...
Background Low socioeconomic status (SES) is linked to increased cardiovascular risk, but its association with carotid atherosclerosis in the general population is less well studied. We examined ...
CINCINNATI (WKRC) - A simple and painless screening could help you avoid a stroke. And Local 12 and St. Elizabeth healthcare are offering them at low cost as part of our Northern Kentucky Community ...
Coverage unlocks reimbursable AI plaque quantification, advancing coronary risk assessment in everyday cardiology practice ...
Coverage unlocks reimbursable AI plaque quantification, advancing coronary risk assessment in everyday cardiology practiceHighlights New permanent Category I CPT code 75577 for AI-enabled coronary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results